COPD News

There has been increasing use of and research on home-based pulmonary rehabilitation during the COVID-19 pandemic, bringing to light numerous benefits of telehealth rehabilitation along with traditional center-based rehabilitation.

Female sex was identified as a main risk factor for depressive symptoms in COPD in a study published in BMC Pulmonary Medicine.

Perioperative combination therapy using a long-acting muscarinic antagonist and long-acting beta agonist may be an optimal treatment for patients with lung cancer and COPD undergoing cancer for lung surgery, researchers reported.

Patients with COPD who received care in an accredited advanced COPD center of excellence clinic had lower ED use compared with those who received care at another center, researchers reported.

The Healio Editors have compiled a list of the most-read news in pulmonology posted in July.

High genetic risk and preexisting COPD are both independently associated with increased risk for severe COVID-19, according to data published in the Annals of the American Thoracic Society.

A new study published in Respiratory Medicine identified approaches for success in establishing a rapid access rehabilitation program following hospitalization for acute exacerbations of COPD.

This week, low-dose azithromycin did not improve cough in patients with IPF; tele-pulmonary rehab may lower barriers to care; the J&J vaccine protects against the delta variant; and more.

Palliative care is increasingly being implemented for nonmalignant diseases such as severe COPD, and a new study identified unmet needs of patients, caregivers and health professionals.

A community-based telehealth pulmonary rehabilitation program for patients with COPD was accessible, feasible and safe, researchers reported in the Annals of the American Thoracic Society.